Compare Indomobil Sukses Internasional Tbk. (IMAS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indomobil Sukses Internasional Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Indomobil Sukses Internasional Tbk. trades at Rp835 (market cap 3.28T, 63.9K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 3.4× Indomobil Sukses Internasional Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 63.9K). Which is the better fit depends on your goals.
| IMAS | TSPC | |
|---|---|---|
Market Cap | 3.28T | 11.18T |
Volume | 63.9K | 613K |
Lot | 639 | 6.13K |
Turnover | 53.08M | 1.54B |
Average Price | 830.74 | 2,511.52 |
Value | 53.08M | 1.54B |
Indicative Equilibrium Price | 825 | 2,520 |
Indicative Equilibrium Volume | 2 | 17 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indomobil Sukses Internasional Tbk.
PT Indomobil Sukses International Tbk (the Company) was initially established as a result of the merger between PT Indomulti Inti Industri Tbk (IMII) and PT Indomobil Investment corporation (IIC). The Company’s articles of association has been amended from time to time, most recently on June 30, 1999 in connection with the Company’s plans to offer shares with pre-emptive right. The Ministry of Justice has approved the amendment on July 5, 1999.
Read more on IMAS →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
